HAEMONETICS CORPORATION (HAE) Free cash flow 2017–2026
HAEMONETICS CORPORATION (HAE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$260.4MFY2026 · since FY2017: $83.6M → $260.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $260.4M | +82.8% |
| FY2025 | $142.4M | -0.8% |
| FY2024 | $143.6M | +75.7% |
| FY2023 | $81.7M | +7.9% |
| FY2022 | $75.8M | +5.6% |
| FY2021 | $71.8M | -34.4% |
| FY2020 | $109.5M | +171.5% |
| FY2019 | $40.3M | -72.3% |
| FY2018 | $145.6M | +74.1% |
| FY2017 | $83.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice